Latest News
The UAB Department of Otolaryngology-Head and Neck Surgery has expanded its thyroid care offerings with the launch of a radiofrequency ablation (RFA) program, providing a minimally invasive, non-surgical treatment option for patients with benign thyroid nodules.
Cancer cells live under constant siege, generating a steady barrage of DNA damage that many therapies push even further, yet tumors so often survive and come back resistant. New research from Wioletta Czaja, Ph.D., assistant professor in the Department of Genetics, points to one reason why: a chromatin regulator called HELLS that helps cancer cells repair damaged DNA and stay a step ahead of treatment.
The UAB Medicine Leadership Development Office (LDO) recently recognized 11 individuals in its ninth cohort of its LEading, Advancing, Developing (LEAD) program. The fall 2026 graduates received their certificates on Sept. 3.
Roxanne Lockhart, M.D., recently joined the UAB Department of Neurology as an assistant professor in the Division of Epilepsy, bringing a rich history of connection and dedication to the institution.
Kyle Wood, M.D., MBA, associate professor in the UAB Department of Urology, is pioneering a new handheld robotic ultrasound-guidance device that changes how physicians access the kidney during stone surgery. The technology is designed to help surgeons precisely target the kidney, usually one of the more technically challenging steps. For Wood, this has allowed for smaller incisions, less trauma to the kidneys, and quicker recovery times.
This month, we meet researcher John Mullin, who works in the labs of clinical diabetes researchers Rita Basu, M.D., and Ananda Basu, M.D. studying glucose metabolism.
The University of Alabama at Birmingham (UAB) and Children’s of Alabama have been named a Team Telomere Center of Excellence for Telomere Biology Disorders (TBDs). The designation recognizes the institutions’ commitment to providing comprehensive, coordinated care while advancing research, education, collaboration and advocacy for patients and families affected by these rare conditions.
The University of Alabama at Birmingham Department of Neurosurgery Kristen Lamb, PA-C, has received a 2026 UAB Medicine Excellence Award, the highest honor for staff members.
Amy Warriner, M.D., UCDC scientist and professor in the Department of Medicine Division of Endocrinology, Diabetes and Metabolism, was a special guest on the Arthritis Foundation’s Live Yes! with Arthritis podcast where she discussed tips for living with diabetes and arthritis.
Mason Aldridge, MSN, RN, a newly-welcomed advanced practice provider (APP) in the University of Alabama at Birmingham Department of Neurosurgery, has already forged a noteworthy career in both nursing care and advocacy.
The University of Alabama at Birmingham Department of Neurosurgery welcomes Addison Lusco as a communications intern.
The UAB Department of Anesthesiology and Perioperative Medicine recently welcomed Joseph Anderson, M.D., as an assistant professor.
The UAB Department of Otolaryngology-Head and Neck Surgery recently welcomed Thomas “Gil” Townes, M.D., as an assistant professor in the Division of Head and Neck Oncology/Endocrine.
Abdelrahman Abdelazim, MBBCH, joined the UAB Department of Radiology as an assistant professor in the Division of Interventional Radiology in August 2026. Learn more about his journey and what inspires his work.
Members of the UAB Department of Surgery were recognized this year with Patient Experience Hero Awards and Clinical Excellence in Nursing Awards, highlighting their commitment to delivering exceptional patient-centered care across the health system.
A study led by Jacques Wadiche, Ph.D., and Linda Overstreet-Wadiche, Ph.D., professors in the Department of Neurobiology, was published in Nature Neuroscience, titled "Glutamate concentration tunes AMPA receptor function through conductance-state occupancy." Co-authors include Gokulakrishna Banumurthy, Reagan L. Pennock, Luke T. Coddington, Xiaohui Yan, and Gabrielle N. Smith.
Leveraging a five-year, $3.7 million grant from the NIH, a new clinical trial led by Drew Sayer, Ph.D., assistant professor in the UAB Department of Family and Community Medicine, is exploring strategies for improving obesity treatment for aging adults.
UAB researchers are part of an international study investigating a drug that could potentially stop or slow bleeding in the brain, also known as an intracerebral hemorrhage. Caused by the rupture of a blood vessel in the brain, intracerebral hemorrhage is the second leading cause of stroke, responsible for up to 30 percent of all strokes.
Has your child been struggling to read the board, avoiding reading or complaining of headaches since school started? Vision problems can affect how children learn and participate in the classroom, but children may not realize they are having trouble seeing.
The University of Alabama at Birmingham (UAB) Department of Pediatrics is proud to announce that Namasivayam Ambalavanan, M.D., has been named Executive Vice Chair for Research.
Owen Leitzel, a graduate student in the lab of Stefanie Robel, Ph.D. — associate professor in the Department of Cell, Developmental, and Integrative Biology — has been awarded an NIH F31 fellowship to support his research investigating the role of connexin43, or Cx43, in seizure susceptibility after traumatic brain injury.
The University of Alabama at Birmingham's Center for Addiction and Pain Prevention and Intervention (CAPPI) announces a leadership transition as Karen Cropsey, PsyD, Professor of Psychiatry and Behavioral Neurobiology, Kathy Ireland Endowed Chair for Psychiatric Research, and Vice Chair for Clinical Research, departs UAB to pursue a new opportunity at Oklahoma University Medical Center.
The UAB Medicine Leadership Development Office (LDO) recently recognized 14 individuals in its ninth cohort of Sharing Authentically to Inspire and Lead (SAIL). The fall 2026 graduates received their certificates on Sept. 1.
The University of Alabama at Birmingham Department of Neurosurgery Kristen Lamb, PA-C, and Amber Virdell, patient services coordinator at The Kirklin Clinic, have been named UAB Medicine 2026 Patient Experience Heroes.
The University of Alabama at Birmingham Department of Neurosurgery Division of Pediatric Neurosurgery Professor Brandon Rocque, M.D.,Brandon Rocque, M.D., and Assistant Professor Elizabeth McRae, Ph.D.,Elizabeth McRae, Ph.D., recently presented at the Hydrocephalus Association's largest research workshop to date.
The University of Alabama at Birmingham Department of Neurosurgery welcomes Mason Aldridge, MSN, RN, as an advanced practice provider (APP).
The Birmingham-Jefferson County Transit Authority, operator of MAX Transit, is renewing its partnership with the University of Alabama at Birmingham’s Equal Access Birmingham to help address transportation insecurity in the Birmingham area.
The Department of Cell, Developmental, and Integrative Biology congratulates ten trainees who have been appointed or reappointed to competitive NIH T32 training grants for the 2026-2027 funding period.
Breast cancer is one of the leading causes of death for women worldwide. HER2, or human epidermal growth factor receptor 2, is a protein found on the surface of some cells in the body that regulate normal cell growth. In HER2-positive breast cancer, tumor cells have higher levels of HER2 proteins than normal cells. This can cause the cells to grow and divide more quickly, which can make the cancer more aggressive. With the development of medicines that specifically target and block the HER2 protein, most patients with HER2-positive breast cancer can benefit from HER2-targeted therapy. Breast cancer can be classified by HER2-positive and HER2-negative subtypes and by hormonal receptor status, which helps guide treatment decisions, including hormonal therapy.
The UAB Comprehensive Diabetes Center (UCDC) has selected four recipients for its 2026 Seed Funding Program focused on Precision Diabetes.